Internal Medicine - Issue 12/2019
739
Guidelines
743
Stanovisko výboru České společnosti pro aterosklerózu k doporučením ESC/EAS pro diagnostiku a léčbu dyslipidemií z roku 2019
Michal Vrablík, Jan Piťha, Vladimír Bláha, Renata Cífková, Tomáš Freiberger, David Karásek, Pavel Kraml, Hana Rosolová, Vladimír Soška, Tomáš Štulc, Zuzana Urbanová
755
Original Contributions
761
Hyperlipidemia management in Slovakia: observational study
Ubomíra Fábryová, Alena Nemcová
770
Vascular age
Ondřej Petrák, Richard Češka
775
Atherosclerosis in patients with type 1 diabetes
David Karásek
783
Hypertriglyceridemia and atherosclerosis risk
Rudolf Poledne, Jan Kovář
788
Extermination of atherosclerosis not only in lower extremities
Jan Piťha, Věra Boháčová
795
Atherosclerosis and beta-blockade: A forgotten option?
Michal Vrablík, Eva Tůmová
802
Pharmacologically induced thyreopathy in patients with cardiovascular disease
Tomáš Brutvan, Jan Krátký, Jana Ježková
809
Internal Medicine
2019 Číslo 12
Najčítanejšie v tomto čísle
- Pharmacologically induced thyreopathy in patients with cardiovascular disease
- Vascular age
- Hypertriglyceridemia and atherosclerosis risk
- Notes on the new “Recommendations for the treatment of dyslipidemia. Influencing of lipids to reduce cardiovascular risk”